Envoy Medical (NASDAQ:COCH) Stock Price Crosses Below 200-Day Moving Average – Time to Sell?

Shares of Envoy Medical, Inc. (NASDAQ:COCH) crossed below its 200-day moving average during trading on Thursday. The stock has a 200-day moving average of $6.88 and traded as low as $6.80. Envoy Medical shares last traded at $6.81, with a volume of 12,917 shares trading hands.

Envoy Medical News Roundup

Investors following COCH have been watching these news items:

• Positive Sentiment: HC Wainwright raised its FY2026 EPS estimate to a loss of $2.61 from a projected loss of $3.10, indicating a smaller expected loss. The firm maintained its Buy rating and $18 price target.
• Positive Sentiment: Short interest fell 84.4% in October, potentially reflecting reduced bearish positioning. Envoy Medical Shares Shorted: Short Interest Down 84.4% in October
• Negative Sentiment: HC Wainwright cut its loss estimates for each quarter of 2027 and for full-year 2027. Its FY2027 EPS forecast moved to a loss of $2.25 from $1.80, signaling expectations of deeper losses than previously forecast.

Analyst Ratings Changes

A number of research analysts have issued reports on COCH shares. Lake Street Capital lifted their price objective on Envoy Medical from $2.50 to $25.00 and gave the company a “buy” rating in a research note on Tuesday, October 27th. Weiss Ratings reissued a “sell (e+)” rating on shares of Envoy Medical in a research note on Monday, October 19th. Loop Capital set a $20.00 price target on Envoy Medical in a report on Monday, July 27th. Finally, HC Wainwright restated a “buy” rating and set a $18.00 price target on shares of Envoy Medical in a report on Monday. Two equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $21.00.

Envoy Medical Price Performance

The company has a market capitalization of $52.57 million, a PE ratio of -1.48 and a beta of 2.03. The firm has a 50-day moving average of $6.81 and a 200 day moving average of $6.88.

Envoy Medical (NASDAQ:COCH) last released its quarterly earnings data on Thursday, November 5th. The company reported ($0.50) EPS for the quarter, topping the consensus estimate of ($0.67) by $0.17. Envoy Medical had a negative return on equity of 5,250.23% and a negative net margin of 9,026.41%. The company had revenue of $0.07 million during the quarter, compared to the consensus estimate of $0.09 million. Equities analysts expect that Envoy Medical, Inc. will post -2.61 EPS for the current year.

Envoy Medical Company Profile

Envoy Medical is a medical technology company focused on developing fully implanted hearing devices for people with sensorineural hearing loss. Unlike conventional hearing aids and many cochlear implants, its technology is designed to be placed beneath the skin, with no external wearable sound processor. The company’s lead product is the Acclaim Cochlear Implant, a fully implanted cochlear implant intended to address moderate-to-profound sensorineural hearing loss in adults. The system is designed to use the body’s natural anatomy to capture sound and convert it into electrical signals that stimulate the auditory nerve.